These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12219588)

  • 21. The clinical spectrum of the oculo-respiratory syndrome after influenza vaccination.
    De Serres G; Grenier JL; Toth E; Ménard S; Roussel R; Tremblay M; Fradet MD; Landry M; Robert Y; Skowronski DM
    Vaccine; 2003 Jun; 21(19-20):2354-61. PubMed ID: 12744866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adverse ocular effects following influenza vaccination.
    Solomon A; Siganos CS; Frucht-Pery J
    Eye (Lond); 1999 Jun; 13 ( Pt 3a)():381-2. PubMed ID: 10624444
    [No Abstract]   [Full Text] [Related]  

  • 23. Co-morbidities associated with influenza-attributed mortality, 1994-2000, Canada.
    Schanzer DL; Langley JM; Tam TW
    Vaccine; 2008 Aug; 26(36):4697-703. PubMed ID: 18620016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative trial of influenza immunization by inhalation and hypojet methods.
    Haigh W; Howell RW; Meichen FW
    Practitioner; 1973 Sep; 211(263):365-70. PubMed ID: 4586238
    [No Abstract]   [Full Text] [Related]  

  • 25. Hospital-based influenza vaccination of children: an opportunity to prevent subsequent hospitalization.
    Zerr DM; Englund JA; Robertson AS; Marcuse EK; Garrison MM; Christakis DA
    Pediatrics; 2008 Feb; 121(2):345-8. PubMed ID: 18245426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influenza vaccination in the 2006-2007 season].
    Alexandrescu V; Ioniţă E; Lupulescu E; Mihăilă D; Samoilă N; Apostol I; Pistol A; Canton A
    Bacteriol Virusol Parazitol Epidemiol; 2007; 52(1-2):69-74. PubMed ID: 18441961
    [No Abstract]   [Full Text] [Related]  

  • 27. Statement on influenza vaccination for the 2005-2006 season. An advisory committee statement.
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2005 Jun; 31(ACS-6):1-30. PubMed ID: 15959943
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunogenicity and tolerability of inactivated flu vaccine in high risk and healthy children.
    Avila Aguero ML; Soriano-Fallas A; Umaña-Sauma MA; Ulloa-Gutierrez R; Arnoux S
    Medicina (B Aires); 2007; 67(4):351-9. PubMed ID: 17891930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statement on influenza vaccination for the 1987-88 season.
    Martin S
    CMAJ; 1987 Oct; 137(8):700. PubMed ID: 3651936
    [No Abstract]   [Full Text] [Related]  

  • 30. [Under water exercise].
    Taguchi N
    Nihon Rinsho; 2000 Sep; 58 Suppl():240-4. PubMed ID: 11085122
    [No Abstract]   [Full Text] [Related]  

  • 31. Statement on influenza vaccination for the 2007-2008 season. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2007 Jul; 33(ACS-7):1-38. PubMed ID: 17663034
    [No Abstract]   [Full Text] [Related]  

  • 32. An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season.
    National Advisory Committee on Immunization
    Can Commun Dis Rep; 2003 Aug; 29():1-20. PubMed ID: 12961958
    [No Abstract]   [Full Text] [Related]  

  • 33. Delivering influenza vaccine to pregnant women.
    Naleway AL; Smith WJ; Mullooly JP
    Epidemiol Rev; 2006; 28():47-53. PubMed ID: 16731574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influenza vaccine-associated adverse events: results of passive surveillance, Canada 2001-2002.
    Choudhri Y; Walop W
    Can Commun Dis Rep; 2002 Dec; 28(23):189-96. PubMed ID: 12501745
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.
    Wongsurakiat P; Maranetra KN; Gulprasutdilog P; Aksornint M; Srilum W; Ruengjam C; Sated W
    Respirology; 2004 Nov; 9(4):550-6. PubMed ID: 15612969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza vaccination among Canadians with chronic respiratory disease.
    Vozoris NT; Lougheed MD
    Respir Med; 2009 Jan; 103(1):50-8. PubMed ID: 18818066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
    Iskander J; Broder K
    Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with inactivated, virosomal influenza vaccine.
    de Bruijn IA; Nauta J; Cramer WC; Gerez L; Palache AM
    Vaccine; 2005 Jul; 23 Suppl 1():S39-49. PubMed ID: 16005120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morbidity by upper respiratory tract diseases in a semi-closed community, after intranasal application of an inactivated influenza vaccine.
    Steiner N; Petrescu A; Mihail A; Steiner G; Călina A
    Virologie; 1981; 32(4):307-9. PubMed ID: 7331237
    [No Abstract]   [Full Text] [Related]  

  • 40. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.